Introduction
Onconephrology is an emerging discipline that covers the interrelations between cancer and kidney diseases (1) . Acute kidney injury (AKI) is a common complication in patients with cancer, and indeed certain clinical entities, such as tumor lysis syndrome and syndrome of inappropriate antidiuretic hormone have close associations with cancer (2) . With the wider use of chemotherapeutic regimens and targeted therapies, the link between kidney disease and cancer has unfortunately become stronger. Not only is cancer often associated with abnormalities that affect the kidney, but renal dysfunction itself cause interruptions in therapy and increased hospital length of stay, cost, and mortality(3).
A sound knowledge and understanding about the aetiology and risk factors leading to AKI in these patients will help to devise various interventions at appropriate times and improve the overall outcome. To our knowledge no studies were available on Indian population, thus this study is undertaken to evaluate the clinical profile of AKI in cancer patients of Dakshina Karnataka.
II. Aims And Objectives
To assess the 1) Clinical profile of AKI in cancer patients 2) Incidence of AKI in cancer patients
III. Materials And Methods
Study design: Cross-sectional study Methodology: Standard demographic data (age, gender, & occupation) was obtained from all participants enrolled. Clinical data include the admitting diagnosis, presence of co-morbidities (hypertension, diabetes mellitus & coronary artery disease). The data on renal function includes urine microscopy, blood urea, serum creatinine, serum electrolytes, serum calcium, serum bicarbonate, serum phosphorous.
IV. Statistical Analysis
Data was analyzed by frequency, percentage, mean, standard deviation. 
VI. Discussion
The association between kidney disease and cancer has been long recognized. With the wider use of chemotherapeutic regimens and the introduction of many targeted therapies, the link between kidney disease and cancer has unfortunately become stronger. Not only is cancer often associated with abnormalities that affect the kidney, but cancer therapy often leads to both acute and chronic kidney injury. 4 In this study it was found that the incidence of AKI was 11.3 %, which was comparable to a recent analysis of 3560 patients admitted to the University of Texas M.D. Anderson Cancer Centre in Houston over 3 months which revealed an incidence rate of AKI of 14.5%. 5 In a study done by Soares et al, among 975 patients, 309 (32%) had renal dysfunction 6 . In present study of 26 cancer patients with AKI, 75% had solid tumors and 25% had hematologic malignancies. In SOAP study, of 473 patients with cancer malignancy, 85 % solid cancer, and 15 % haematological cancer. 7 Sepsis is the most common cause of AKI in patients with cancer. 8 Cancer has been reported in about 17% of medical admissions associated with sepsis. 9 This study showed, common cause of AKI was multifactorial in 30.8%, followed by hypovolemia (38.5%), sepsis (30.8%) and hypercalcemia (23.1%); all of the patients requiring dialysis and one who died presented with septic shock. Soares et al, 6 in their study showed In study done by Soares et al, there was complete recovery of renal function in 82% and partial recovery in 12%, and chronic dialysis was needed in only 6% of patients. 6 In this study renal function completely improved in 80.7% patients and 15.4% required chronic dialysis.
VII. Conclusion
AKI is a complication in cancer patients that results from various causes, including metabolic disturbances secondary to the sepsis, tumor burden, renal infiltration by malignant cells and drug-induced toxicity.Thorough evaluation to assess for general and cancer-related etiologies can assist in managing the patient in best possible way. When evaluating prognosis in these patients, older age, cancer status and the severity of associated organ dysfunction are important variables to take into consideration.
